Thymosin Alpha-1 Mechanism of Action Detailed: Comparison Table
Dendritic Cell Maturation Increases CD80/CD86 expression by 40–55% TLR9 → MyD88 → NF-κB activation Improved antigen presentation to naive T-cells Most critical effect. Determines downstream T-cell activation CD4+ Helper T-Cells 18–24% increase from baseline (1
This comparison does not assign a generated winner or score.
- Dendritic Cell Maturation
- Increases CD80/CD86 expression by 40–55%
- TLR9 → MyD88 → NF-κB activation
- Improved antigen presentation to naive T-cells
- Most critical effect. Determines downstream T-cell activation
- CD4+ Helper T-Cells
- 18–24% increase from baseline (12 weeks)
- Enhanced thymopoietin expression in thymic epithelium
- Restored immune coordination in immunocompromised states
- Moderate but consistent. Not immediate
- CD8+ Cytotoxic T-Cells
- 35% increased lytic activity per cell
- Upregulated perforin/granzyme B via calcium signalling
- Direct pathogen and tumour clearance capacity
- Functional enhancement outweighs numerical expansion
- Regulatory T-Cells (Tregs)
- 12–16% population increase
- IDO-mediated tryptophan metabolism favouring Treg survival
- Prevents autoimmune activation during immune upregulation
- Unique to thymosin alpha-1. Rare in immune activators
- Natural Killer Cells
- 22–28% cytotoxicity increase
- Direct granzyme/perforin upregulation independent of T-cells
- Innate tumour surveillance and viral defence
- Fills gaps T-cell responses miss
- IL-2 Production
- 2.5–3.2× baseline levels
- NF-κB-mediated transcription in activated T-cells
- Drives T-cell proliferation and memory formation
- Central to sustained immune response
- IFN-γ Production
- 2.8–3.5× baseline levels
- IRF-7 activation downstream of TLR9
- Activates macrophages, enhances MHC-I presentation
- Critical for intracellular pathogen clearance